XTLB Stock Analysis: Buy, Sell, or Hold?
XTLB - XTL Biopharmaceuticals Ltd. American Depositary Shares
$2.73
0.37 (15.68%)
▲
5d:
-2.15%
30d:
+11.89%
90d:
+4.6%
HOLD
MODERATE Confidence
Analysis Updated: Jun 30, 2026 12:00 AM ET
Earnings: Apr 29, 2026
0d
Get Alerted When XTLB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: XTLB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: XTLB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: XTLB is currently trading at $2.73, which is considered extended relative to its 30-day fair value range of $2.22 to $2.60.
Technical Outlook: Technically, XTLB is in a strong uptrend. The price is approaching resistance at $2.59. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 15.7% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $30.00 (+998.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, XTLB is in a strong uptrend. The price is approaching resistance at $2.59. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 15.7% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $30.00 (+998.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.22 -
$2.60
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
56.3%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+15.7%)
- BULLISH: Trading 998.9% below Wall St target ($30.00)
Trading Range Analysis
30-Day Trading Range
$2.22 -
$2.60
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.01
Resistance Level
$2.59
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Wall Street Target
$30.00
(+998.9%)
Earnings Growth (YoY)
-76.0%
Share & Embed Analysis
Last updated: July 01, 2026 2:54 AM ET
Data refreshes hourly during market hours. Next update: 3:54 AM
Data refreshes hourly during market hours. Next update: 3:54 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XTLB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$436 | 58 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 58 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 66 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 62 BUY |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 58 HOLD |